133 related articles for article (PubMed ID: 14984964)
1. Transcriptional activation of H- and N-ras oncogenes in human cervical cancer.
Mammas IN; Zafiropoulos A; Koumantakis E; Sifakis S; Spandidos DA
Gynecol Oncol; 2004 Mar; 92(3):941-8. PubMed ID: 14984964
[TBL] [Abstract][Full Text] [Related]
2. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix.
O'Leary JJ; Landers RJ; Silva I; Uhlmann V; Crowley M; Healy I; Luttich K
J Clin Pathol; 1998 Aug; 51(8):576-82. PubMed ID: 9828814
[TBL] [Abstract][Full Text] [Related]
4. K-ras mutations and HPV infection in cervicitis and intraepithelial neoplasias of the cervix.
Prokopakis P; Sourvinos G; Koumantaki Y; Koumantakis E; Spandidos DA
Oncol Rep; 2002; 9(1):129-33. PubMed ID: 11748470
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus (HPV) typing in relation to ras oncogene mRNA expression in HPV-associated human squamous cervical neoplasia.
Mammas IN; Zafiropoulos A; Sifakis S; Sourvinos G; Spandidos DA
Int J Biol Markers; 2005; 20(4):257-63. PubMed ID: 16398408
[TBL] [Abstract][Full Text] [Related]
6. Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPV-associated high grade dysplasia and squamous cell cervical carcinoma.
Pochylski T; Kwaśniewska A
Eur J Obstet Gynecol Reprod Biol; 2003 Nov; 111(1):68-73. PubMed ID: 14557015
[TBL] [Abstract][Full Text] [Related]
7. Detection of HPV and ras gene mutations in cervical smears from female genital lesions.
Dokianakis DN; Sourvinos G; Sakkas S; Athanasiadou E; Spandidos DA
Oncol Rep; 1998; 5(5):1195-8. PubMed ID: 9683834
[TBL] [Abstract][Full Text] [Related]
8. Association between activated K-ras and c-erbB-2 oncogenes with "high-risk" and "low-risk" human papilloma virus types in preinvasive cervical lesions.
Mourón SA; Abba MC; Güerci A; Gómez MA; Dulout FN; Golijow CD
Mutat Res; 2000 Aug; 469(1):127-34. PubMed ID: 10946249
[TBL] [Abstract][Full Text] [Related]
9. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
10. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
[TBL] [Abstract][Full Text] [Related]
11. Coexisting high-grade glandular and squamous cervical lesions and human papillomavirus infections.
Bekkers RL; Bulten J; Wiersma-van Tilburg A; Mravunac M; Schijf CP; Massuger LF; Quint WG; Melchers WJ
Br J Cancer; 2003 Sep; 89(5):886-90. PubMed ID: 12942122
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus genotyping by oligonucleotide microarray and p16 expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women.
Lin ZH; Shen XH; Jin Z; Kim Y; Lee E; Kim H; Kim I
Pathol Int; 2005 Aug; 55(8):491-6. PubMed ID: 15998377
[TBL] [Abstract][Full Text] [Related]
13. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV.
Hopman AH; Kamps MA; Smedts F; Speel EJ; Herrington CS; Ramaekers FC
Int J Cancer; 2005 Jun; 115(3):419-28. PubMed ID: 15688369
[TBL] [Abstract][Full Text] [Related]
14. The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix.
Kumar R; Mandal S; Arora P; Mala YM; Khurana N
J Obstet Gynaecol; 2021 Jul; 41(5):785-790. PubMed ID: 33073644
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus (EBV) genes expression in cervical intraepithelial neoplasia and invasive cervical cancer: a comparative study with human papillomavirus (HPV) infection.
Sasagawa T; Shimakage M; Nakamura M; Sakaike J; Ishikawa H; Inoue M
Hum Pathol; 2000 Mar; 31(3):318-26. PubMed ID: 10746674
[TBL] [Abstract][Full Text] [Related]
16. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
17. Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix.
Tenti P; Romagnoli S; Silini E; Pellegata NS; Zappatore R; Spinillo A; Zara C; Ranzani GN; Carnevali L
Int J Cancer; 1995 Feb; 64(1):9-13. PubMed ID: 7665253
[TBL] [Abstract][Full Text] [Related]
18. Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction.
Aoyama C; Peters J; Senadheera S; Liu P; Shimada H
Diagn Mol Pathol; 1998 Dec; 7(6):324-30. PubMed ID: 10207671
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.
Akasofu M; Oda Y
Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216
[TBL] [Abstract][Full Text] [Related]
20. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
